Ravi Salgia to eIF-2 Kinase
This is a "connection" page, showing publications Ravi Salgia has written about eIF-2 Kinase.
Connection Strength
0.567
-
Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer. BMC Cancer. 2016 08 02; 16:568.
Score: 0.567